Status:
COMPLETED
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
Lead Sponsor:
Universidad de Sonora
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Type 2 Diabetes (T2D) is protected against chronic hyperglycemia. This is one of the main causes of death in the country, being a public health problem worldwide. Some studies have shown that herbal p...
Detailed Description
Cinnamon, in in vitro and in vivo studies, has been shown to have biologically active substances with mimetic properties of insulin. In 1990 an unidentified component of cinnamon was extracted and nam...
Eligibility Criteria
Inclusion
- Subjects with a prior medical diagnosis of T2D
- Mexican adults (\> 18 years)
- Treatments only with oral hypoglycemic agents
- HbA1c \>6.5% and \<10%
- Attendees to two participating primary health care centers.
Exclusion
- Patients who have an allergy to cinnamon or wheat flour.
- Treatments with insulin
- Gastrointestinal problems or any condition in cinnamon is not well tolerated or contraindicated
- Cardiovascular, hepatic or renal disease.
- Use of addictive substances as drugs.
- Pregnant or lactation
- Psychiatric condition that prevents adherence to treatment
- Use of a supplement with an effect on glucose
Key Trial Info
Start Date :
September 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 23 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04023539
Start Date
September 4 2019
End Date
April 23 2020
Last Update
May 28 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
C.A.A.P.S.
Hermosillo, Sonora, Mexico, 83000
2
ISSSTE Family Medicine Clinic
Hermosillo, Sonora, Mexico, 83140